Lumakras® (sotorasib)
for Lung Cancer

Lumakras (sotorasib) is a targeted therapy for KRAS G12C-mutated non-small cell lung cancer (NSCLC) and metastatic colorectal cancer (mCRC). It is used in NSCLC after prior treatment and in mCRC with panitumumab following specific chemotherapy. Lumakras inhibits the KRAS G12C protein, slowing cancer growth while sparing normal proteins.

Heart